Intuitive Surgical, Inc. $ISRG Stock Holdings Lifted by Swedbank AB

Key Points

• Swedbank AB increased its stake in Intuitive Surgical by 34.7%, holding 528,414 shares valued at $287.15 million, as reported in its recent 13F filing.
• Intuitive Surgical reported a quarterly EPS of $2.19, exceeding analyst expectations of $1.93, with a revenue of $2.44 billion, up 21.4% year-over-year.
• Analysts maintain a consensus rating of "Moderate Buy" for Intuitive Surgical, with a target price around $595.95, reflecting confidence in the company's growth potential despite recent stock performance.

Swedbank AB lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 34.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 528,414 shares of the medical equipment provider's stock after buying an additional 136,065 shares during the period. Swedbank AB owned about 0.15% of Intuitive Surgical worth $287,145,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of ISRG. Nuveen LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. GAMMA Investing LLC boosted its holdings in Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after acquiring an additional 3,022,979 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after purchasing an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Finally, Wellington Management Group LLP increased its position in Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 price target (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. BTIG Research upped their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Finally, Truist Financial increased their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Insider Activity

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 over the last ninety days. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

ISRG traded up $6.22 during trading on Monday, reaching $444.94. The company's stock had a trading volume of 967,141 shares, compared to its average volume of 2,039,215. The company's fifty day moving average price is $476.64 and its 200-day moving average price is $503.43. The company has a market capitalization of $159.50 billion, a price-to-earnings ratio of 62.02, a price-to-earnings-growth ratio of 4.60 and a beta of 1.61. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 EPS. Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.